Cytokinetics Inc (CYTK) stock
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$56.13−0.03 (-0.05%)
Close on Nov 13, 2026Market cap $7.80BP/E –Yield –
Cytokinetics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cytokinetics's enterprise value was -$1.42B on Nov 11, 2026, against -$1.12B a year earlier. Over the last 5 years it ranged from -$1.42B to $7.19B, with a median of -$560.16M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.42B | – |
| 2025 | Dec 31, 2025 | -$1.12B | – |
| 2024 | Dec 31, 2024 | -$1.19B | – |
| 2023 | Dec 29, 2023 | -$485.85M | – |
| 2022 | Dec 30, 2022 | -$800.13M | – |
| 2021 | Dec 31, 2021 | -$427.21M | – |
| 2020 | Dec 31, 2020 | -$363.06M | -211.3% |
| 2019 | Apr 30, 2019 | $326.32M | +87.1% |
| 2018 | Dec 31, 2018 | $174.39M | +8.3% |
| 2017 | Dec 29, 2017 | $161.08M | -63.0% |
| 2016 | Dec 30, 2016 | $435.72M | +41.7% |
| 2015 | Dec 31, 2015 | $307.39M | +45.9% |
| 2014 | Dec 31, 2014 | $210.74M | +98.1% |
| 2013 | Dec 31, 2013 | $106.37M | +731.5% |
| 2012 | Dec 31, 2012 | $12.79M | +8.4% |
| 2011 | Dec 30, 2011 | $11.80M | -87.7% |
| 2010 | Dec 31, 2010 | $95.58M | – |
See a number that looks wrong?